Skip to content

Erasca, Inc. ERAS Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Pfizer logo
PfizerPFE
5.7B+0.4%
Amgen logo
AmgenAMGN
544M+0.6%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
198.1M+5.3%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
162.2M+43.1%
Exelixis logo
ExelixisEXEL
267.3M-7.2%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.25B+1,196%
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s shares (diluted)?
Erasca, Inc. (ERAS) reported shares (diluted) of 304.3M in Q1 2026.
How has Erasca, Inc.'s shares (diluted) changed year-over-year?
Erasca, Inc.'s shares (diluted) increased by 7.4% year-over-year, from 283.3M to 304.3M.
What is the long-term trend for Erasca, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Erasca, Inc.'s shares (diluted) has grown at a 52.2% compound annual growth rate (CAGR), from 211.2M to 1.1B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.